SynthesisPharmacological reports : PR2021

Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis.

Raymond Pranata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.